Paid Clinical Trials for Hodgkin Lymphoma

Showing 1 – 20 of 27 results

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

by CTG

in Hodgkin Lymphoma

Other

California

Deadline:

10/01/2028

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

by CTG

in Non Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Refractory, Non-Hodgkin Lymphoma, Relapsed

Other

California

Deadline:

02/28/2028

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

by CTG

in Hodgkin Lymphoma, Non-Hodgkin Lymphoma

Other

Alaska

Deadline:

02/01/2030

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

by CTG

in Hodgkin Lymphoma

Other

Florida

Deadline:

04/01/2027

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

by CTG

in Acute Leukemia, Hodgkin Lymphoma, Severe Aplastic Anemia, Non-Hodgkin Lymphoma, Kostmann

Other

New York

Deadline:

12/31/2027

Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL

by CTG

in Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult

Other

Illinois

Deadline:

08/01/2026

Auto Stem Cell Transplant for Lymphoma Patients

by CTG

in Hodgkin Lymphoma, Non-Hodgkin Lymphoma

Other

Minnesota

Deadline:

04/30/2027

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

by CTG

in Glioblastoma Multiforme (GBM), Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Diffuse Intrinsic Pontine Glioma (DIPG)

Other

California

Deadline:

10/13/2026

Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

by CTG

in Obstructive Sleep Apnea, Hodgkin Lymphoma

Other

Tennessee

Deadline:

07/10/2028

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

by CTG

in Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma

Other

Pennsylvania

Deadline:

06/01/2028

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study

by CTG

in Multiple Myeloma, Leukemia, Hodgkin Lymphoma, Myeloid Leukemia, Lymphoid Leukemia

Other

Nebraska

Deadline:

02/01/2032

Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

by CTG

in Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma

Other

Illinois

Deadline:

12/01/2027

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

by CTG

in Hodgkin Lymphoma, Relapsed or Refractory Hodgkin Lymphoma

Other

Florida

Deadline:

08/01/2026

Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

by CTG

in Hodgkin Lymphoma

Other

Florida

Deadline:

06/01/2026

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

by CTG

in Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma

Other

Arizona

Deadline:

04/30/2026

Improving Exercise Capacity With a Tailored Physical Activity Intervention

by CTG

in Non Hodgkin Lymphoma, Quality of Life, Hodgkin Lymphoma, Stage I Breast Cancer, Heart; Functional Disturbance

Other

North Carolina

Deadline:

08/31/2026

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

by CTG

in Hodgkin Lymphoma

Other

Tennessee

Deadline:

01/01/2029

Integrated Actionable Aging Assessment for Cancer Patients Pilot

by CTG

in Breast Cancer, Leukemia, Hodgkin Lymphoma, Kidney Cancer, Lymphoid Leukemia

Other

Colorado

Deadline:

12/01/2026

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

by CTG

in Hodgkin Lymphoma

Other

Michigan

Deadline:

04/01/2028

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

by CTG

in Hodgkin Lymphoma

Other

Alabama

Deadline:

02/13/2027

Load more All clinical trials loaded.

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL

Auto Stem Cell Transplant for Lymphoma Patients

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study

Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Improving Exercise Capacity With a Tailored Physical Activity Intervention

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

Integrated Actionable Aging Assessment for Cancer Patients Pilot

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Hodgkin Lymphoma

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps